Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network

DSpace Repository

Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network

Author: Hermine, Olivier; Hoster, Eva; Walewski, Jan; Bosly, Andre; Stilgenbauer, Stephan; Thieblemont, Catherine; Szymczyk, Michal; Bouabdallah, Reda; Kneba, Michael; Hallek, Michael; Salles, Gilles; Feugier, Pierre; Ribrag, Vincent; Birkmann, Josef; Forstpointner, Roswitha; Haioun, Corinne; Haenel, Mathias; Casasnovas, Rene Olivier; Finke, Juergen; Peter, Norma; Bouabdallah, Kamal; Sebban, Catherine; Fischer, Thomas; Duehrsen, Ulrich; Metzner, Bernd; Maschmeyer, Georg; Kanz, Lothar; Schmidt, Christian; Delarue, Richard; Brousse, Nicole; Klapper, Wolfram; Macintyre, Elizabeth; Delfau-Larue, Marie-Helene; Pott, Christiane; Hiddemann, Wolfgang; Unterhalt, Michael; Dreyling, Martin
Tübinger Autor(en):
Kanz, Lothar
Published in: Lancet (2016), Bd. 388, H. 10044, S. 565-575
Verlagsangabe: Elsevier Science Inc
Language: English
Full text: http://dx.doi.org/10.1016/S0140-6736(16)00739-X
ISSN: 1474-547X
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)